Its cell-surface receptor CD44 is a single pass transmembrane glycoprotein expressed by a number of cell types including bone marrow mesenchymal cells, immune cells, embryonic stem cells and cancer stem cells (Levesque and Haynes 1996; Chen et al., 2018; Lee-Sayer et al., 2018). Here, CD44 is linked to cancer.